Cite

HARVARD Citation

    Vinti, L. et al. (2022). Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma. Pediatric blood & cancer. 69 (4), p. n/a. [Online]. 
  
Back to record